SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana (CVNA) is trending with high volatility after its earnings report missed adjusted profit estimates despite record revenue, fueling intense community debate around its business model, heavy reliance on loan sales, and perceived accounting practices amid a lack of clear forward guidance.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is trending due to a significant after-hours rally following its mixed Q4 earnings, where the stock surged despite missing revenue and EPS estimates but provided a strong outlook for Q1 Marketplace GOV. This has sparked a heated debate, with bulls cheering the unexpected rebound and growth prospects, while bears remain skeptical, citing valuation and the earnings misses.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is seeing significant institutional accumulation, highlighted by Cormorant Asset Management's substantial share repurchase, signaling strong confidence in its nanobody pipeline. The community is actively discussing the upcoming Investor Day, anticipating new data for sonelokimab across various inflammatory diseases to reinforce its 'best-in-class' potential and fuel short squeeze and buyout speculation.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

The community is actively discussing Zevra Therapeutics following a recent court ruling granting partial summary judgment against the company in a key licensing dispute, with the potential for substantial financial remedies. This legal development, alongside a new board appointment with M&A experience and a CFO departure, is fueling significant speculation among investors about a potential near-term acquisition, even as Miplyffa expands its global access through new distribution agreements.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending as community discussion highlights potential tailwinds from a proposed cap on credit card interest rates, which many believe favors its merchant-funded buy now, pay later model. This optimism is reinforced by its deepening integrations with major payment platforms and strong user growth, despite ongoing debates surrounding its profitability and recent legal challenges.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is trending due to a significant and sustained downturn, reaching new 52-week lows amidst investor frustration and confusion. The community is actively debating whether the stock has found a bottom, pointing to recent leadership changes, a weaker outlook, and broader macroeconomic concerns affecting pet spending, all while anticipating the upcoming March earnings report for a potential catalyst.

Remitly Global, Inc. engages in the provision of digital financial services for immigrants and their families. The company was founded by Matthew B. Oppenheimer and Joshua Hug on October 3, 2018 and is headquartered in Seattle, WA.

Remitly Global Inc

Remitly Global is trending strongly after delivering better-than-expected Q4 and full-year results, achieving its first full year of GAAP profitability, and providing robust 2026 guidance, driving significant community excitement and trading volume around its growth narrative and strategic advancements in AI and stablecoins.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as market participants react to the latest Fed minutes, which indicated some officials are open to potential rate hikes if inflation persists, challenging previous expectations for rapid rate cuts. This has ignited strong community debate over potential market weakness and perceived 'manipulated' price action, with many anticipating further downside.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is trending after securing Medicare coverage for its NeXT Personal MRD test in lung cancer, a pivotal milestone that the community sees as validating its ultra-sensitive technology and accelerating revenue potential in the rapidly expanding precision oncology market. Investors are closely watching for additional reimbursement approvals, anticipating significant long-term growth and a re-rating of the stock.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending after announcing its acquisition of Kodiak Building Partners, a move the community sees as a significant step in Brad Jacobs' ambitious strategy to consolidate and transform the building materials distribution industry, fueling expectations for further M&A activity and long-term growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
